Management volunteers specific, checkable numbers about the near future — quantified forward commitments it could visibl
The model's full reasoning — Q2 2021 call → NO我们根据提供的财报电话会议记录,判断管理层是否自愿提供了具体的、可核实的近期业务承诺数字或日期,并描述为从当前水平提升的业务。 关键点: - 管理层是否自愿提供具体数字(数量、日期、水平)? - 这些数字是否在近期(约一年内)? - 是否描述为增长或提升? - 是否基于已存在的事物(订单、进度等)? 在记录中,管理层提到了: - 电动自行车:成人款MSRP $3,599,儿童款$2,099,成人款预计9月在美国上市,已可订购。 - K32 UTV:仍在优化,未定最终参数和价格,但计划年底前在美国推出。 - 电池交换平台:计划今年晚些时候举办发布会。 - 悬滑板电机:今年目标300万台,但承认全球航运问题可能减缓,正在努力实现。 - 江西辉翼:预计今年收入约2.5亿元人民币(约4000万美元),并计划半年内扩展电池线。 这些数字中,有些是具体的(如价格、收入目标),但很多是方向性的或未定。管理层是否自愿承诺?他们提到了目标,但有些是“努力实现”,有些是“预计”。是否描述为提升?悬滑板电机去年50万台,今年目标300万台,是提升。但管理层承认航运问题可能影响。江西辉翼收入是新增的。 然而,问题要求“具体、可核实的承诺”,且管理层以承诺方式呈现。管理层说“我们正在努力实现300万台”,这算承诺吗?但语气是“努力”,不是坚定承诺。另外,K32未定。电动自行车有具体价格和上市时间,但那是产品发布,不是业务量承诺。 更关键的是,管理层是否自愿提供这些数字?是的,他们在回答问题时提到,但有些是回应提问。但问题问的是“管理层是否自愿提供”,即主动陈述。在开场陈述中,管理层提到了智能出行领域销售增长,但未给具体数字。在回答问题时,他们给出了具体数字。 但问题要求“管理层自己的话传达一种连贯的姿态:愿意将数字和时间放在公司近期未来上,具体程度创造真实问责,且这些数字描述增长或提升”。这里,悬滑板电机目标300万台是具体数字,但管理层说“正在努力实现”,且承认航运问题,这算承诺吗?可能算,但语气不够坚定。另外,江西辉翼收入预计2.5亿人民币,但那是收购来的,不是现有业务提升。 此外,管理层没有给出整体财务指引,只有这些零散数字。而且,这些数字是否“描述为从当前水平提升”?悬滑板电机从50万到300万是提升,但那是去年数据,今年目标。但管理层说“考虑到全球航运问题可能减缓销售”,所以可能达不到。这算承诺吗? 我认为,管理层没有给出一个连贯的、具体的、可核实的近期承诺,而是零散提及。而且,很多是方向性的。因此,答案应为NO。 但再仔细看,管理层在回答问题时明确给出了电动自行车价格和上市时间,这是具体且可核实的。但那是产品发布,不是业务量承诺。问题问的是“公司自身业务将做什么”,产品发布也算,但需要是“承诺”且“提升”。电动自行车是新产品,算提升,但管理层没有说销量目标。 另外,K32计划年底前推出,但未定参数和价格,所以不算具体。 悬滑板电机目标300万台,但管理层说“正在努力”,且承认困难,所以可能不算坚定承诺。 江西辉翼收入预计,但那是收购来的,且是今年剩余时间,但管理层说“预计”,不是承诺。 综合来看,管理层没有自愿提供具体的、可核实的、描述为提升的承诺。他们更多是回应问题,且语气不够坚定。因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| RCEL | AVITA Medical, Inc. | Q1 2024 | 2024-05-14 | F |
| ERO | Ero Copper Corp. | Q1 2024 | 2024-05-10 | A |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| WEC | WEC Energy Group, Inc. | Q1 2024 | 2024-05-01 | A |
| PDS | Precision Drilling Corporation | Q1 2024 | 2024-04-25 | B |
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| GPRE | Green Plains Inc. | Q4 2023 | 2024-02-07 | F |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| CMG | Chipotle Mexican Grill, Inc. | Q3 2023 | 2023-10-27 | B+ |
| DXLG | Destination XL Group, Inc. | Q2 2023 | 2023-08-24 | D |
| IMAX | IMAX Corporation | Q2 2023 | 2023-07-26 | B+ |
| GGR | Gogoro Inc. | Q1 2023 | 2023-05-11 | D |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SLDP | Solid Power, Inc. | Q1 2023 | 2023-05-08 | C+ |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| DKS | DICK'S Sporting Goods, Inc. | Q4 2022 | 2023-03-07 | B |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| CEIX | CONSOL Energy Inc. | Q4 2022 | 2023-02-07 | B |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| CIG | Companhia Energética de Minas Gerais | Q3 2022 | 2022-11-16 | C+ |
| CHUY | Chuy's Holdings, Inc. | Q3 2022 | 2022-11-05 | C+ |
| TWO | Two Harbors Investment Corp. | Q2 2022 | 2022-08-04 | C+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| SQM | Sociedad Química y Minera de Chile S.A. | Q1 2022 | 2022-05-19 | C+ |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| SLQT | SelectQuote, Inc. | Q2 2022 | 2022-02-07 | F |
| HNRG | Hallador Energy Company | Q3 2021 | 2021-11-09 | C+ |
| FFWM | First Foundation Inc. | Q3 2021 | 2021-10-26 | B |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| PRPO | Precipio, Inc. | Q3 2018 | 2018-11-19 | D |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| MAS | Masco Corporation | Q3 2018 | 2018-10-30 | C |
| CUBI | Customers Bancorp, Inc. | Q3 2018 | 2018-10-26 | C+ |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| ASND | Ascendis Pharma A/S | Q1 2018 | 2018-05-30 | C+ |
| CLMT | Calumet Specialty Products Partners, L.P | Q1 2018 | 2018-05-16 | C+ |
| ITCI | Intra-Cellular Therapies, Inc. | Q4 2017 | 2018-03-01 | D |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| BCE | BCE Inc. | Q2 2017 | 2017-08-05 | B+ |
| GPOR | Gulfport Energy Corporation | Q4 2016 | 2017-02-14 | A |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| LBTYK | Liberty Global's | Q1 2016 | 2016-05-10 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
TWO · Q2 2022 → YESThe question is about whether management volunteers specific, checkable numbers or dates about the company's own business in the near term that show a step-up, grounded in things they can already see....YES The transcript shows management volunteering a concrete, checkable commitment on the RoundPoint acquisition: they expect incremental annual pre-tax earnings of approximately $20 million once the portfolio is fully transferred (with Mary Riskey later confirming $0.45 per share after-tax accretion). They also state they will begin transitioning loans to Round Point as a subservicer later this year and expect the acquisition to close in 2023. These are presented as owned expectations tied to the in-house servicing model they are already executing, describing a clear step-up in earnings and operational activity above the current subservicing level.
CUBI · Q3 2018 → YESThe question is about whether management volunteers specific, checkable numbers or dates about the company's own business in the near term, presenting them as commitments for a step-up from current le...YES Management volunteers concrete, checkable commitments for the near term (next 12–18 months) that describe a clear step-up from current levels and are grounded in things already in motion or in hand. Examples include: - NIM target of 2.75% within 12–18 months, explicitly tied to 3–4 rate hikes and the $495 million securities sale plus $500 million borrowings repayment already executed. - $600 million core-franchise deposit growth + $500–600 million CB digital + $500 million BankMobile white-label deposits next year, building on the $1.
ADPT · Q4 2022 → YESThe question is: Does management volunteer specific, checkable numbers or dates about what the company's own business will do in the near term — quantified forward commitments concrete enough that inv...YES Management volunteers concrete, checkable commitments for 2023 that describe a clear step-up: full-year revenue of $205–215 million (versus $185.3 million in 2022), clonoSEQ test volumes growing more than 50% from the current base, MRD pharma milestones in the mid to high-single-digit millions, community business reaching 20% of total revenue (from 15% currently), and 2023 OpEx (including cost of revenue) slightly below the 2022 level of $385.5 million, with average quarterly cash burn of $40 million.